Expanding the knowledge of oligometastatic disease—but uncertainties remain significant

Most patients with lung cancer present with advanced disease at the time of diagnosis, when local curative therapy is no longer a treatment option. Among patients with early lung cancer, who are initially treated in curative intent, 6–7% will go on to develop oligometastases, where the metastatic spread is limited in number and site (1).